Related references
Note: Only part of the references are listed.Therapy for metastatic melanoma: the past, present, and future
Laura Finn et al.
BMC MEDICINE (2012)
Overexpression of survivin is correlated with increased invasion and metastasis of colorectal cancer
Xiao-Yuan Chu et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
Mechanisms of Resistance to RAF Inhibitors in Melanoma
Andrew E. Aplin et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Antisense Inhibition of Survivin Expression as a Cancer Therapeutic
Rosa A. Carrasco et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Ligand-independent activation of c-Met by fibronectin and α5β1-integrin regulates ovarian cancer invasion and metastasis
A. K. Mitra et al.
ONCOGENE (2011)
The p16(INK4A) tumor suppressor regulates cellular oxidative stress
N. C. Jenkins et al.
ONCOGENE (2011)
α5β1-Integrin Expression Is Essential for Tumor Progression in Experimental Lung Cancer
Jesse Roman et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2010)
Survivin Enhances Motility of Melanoma Cells by Supporting Akt Activation and α5 Integrin Upregulation
Jodi A. McKenzie et al.
CANCER RESEARCH (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
JWA regulates melanoma metastasis by integrin αVβ3 signaling
J. Bai et al.
ONCOGENE (2010)
Mitotic Deregulation by Survivin in ErbB2-Overexpressing Breast Cancer Cells Contributes to Taxol Resistance
Jing Lu et al.
CLINICAL CANCER RESEARCH (2009)
Anti-integrin monoclonal antibodies
Adam Byron et al.
JOURNAL OF CELL SCIENCE (2009)
Loss of E-cadherin promotes ovarian cancer metastasis via alpha(5)-integrin, which is a therapeutic target
Kenjiro Sawada et al.
CANCER RESEARCH (2008)
Lentiviral Transduction of Mammary Stem Cells for Analysis of Gene Function during Development and Cancer
Bryan E. Welm et al.
Cell Stem Cell (2008)
Survivin: Key regulator of mitosis and apoptosis and novel target for cancer therapeutics
Alain C. Mita et al.
CLINICAL CANCER RESEARCH (2008)
New wirings in the survivin networks
D. C. Altieri
ONCOGENE (2008)
A non-RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo
Parisa Khalili et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Mechanisms of disease - Melanoma
Arlo J. Miller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Survivin expression by metastatic melanoma predicts poor disease outcome in patients receiving adjuvant polyvalent vaccine
H Takeuchi et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Interaction between integrin α5 and fibronectin is required for metastasis of B16F10 melanoma cells
F Qian et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Integrin signaling in malignant melanoma
S Kuphal et al.
CANCER AND METASTASIS REVIEWS (2005)
Rapid induction of mitochondrial events and caspase-independent apoptosis in Survivin-targeted melanoma cells
T Liu et al.
ONCOGENE (2004)
Integrin signalling during tumour progression
WJ Guo et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Molecular circuits of apoptosis regulation and cell division control: The survivin paradigm
DC Altieri
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Survivin, bcl-2, bax, and bcl-X gene expression in sentinel lymph nodes from melanoma patients
A Gradilone et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Get a ligand, get a life: integrins, signaling and cell survival
DG Stupack et al.
JOURNAL OF CELL SCIENCE (2002)
Dissemination and growth of cancer cells in metastatic sites
AF Chambers et al.
NATURE REVIEWS CANCER (2002)
Role of integrins in cell invasion and migration
JD Hood et al.
NATURE REVIEWS CANCER (2002)